**Core Concept:** Congestive heart failure (CHF) is a clinical syndrome characterized by symptoms and signs due to an imbalance between cardiac output and peripheral vascular resistance, leading to congestion of pulmonary and systemic circulation. It can be classified into different stages based on the severity of the condition. Hypertensive heart disease, ischemic heart disease, and cardiomyopathies are common causes of CHF.

**Why the Correct Answer is Right:** The patient is suffering from stage II congestive heart failure, which is characterized by the presence of signs and symptoms of congestive heart failure and structural heart disease. These signs and symptoms include crackles at both lung bases, pitting edema affecting both legs, and a low potassium level (hypokalemia) of 3.0 mEq/L.

The correct choice for a diuretic in this scenario is **D** - Spironolactone, an aldosterone receptor antagonist. Spironolactone is a potassium-sparing diuretic, which helps in reducing the symptoms and signs of congestive heart failure by:

1. Reducing sodium and water retention, thereby decreasing pulmonary and systemic congestion.
2. Preserving potassium levels by blocking aldosterone, which is responsible for sodium retention and potassium loss.

**Why Each Wrong Option is Incorrect:**

A. Furosemide (Lasix) is a loop diuretic but is not the most appropriate choice due to the patient's low potassium level. Loop diuretics cause loss of potassium due to their effect on the distal convoluted tubule and collecting ducts in the nephron, leading to increased potassium excretion.

B. Indapamide is a thiazide-like diuretic, which acts in the distal convoluted tubule to increase potassium excretion and decrease sodium retention. However, this option is incorrect due to the patient's low potassium level, suggesting that we should preserve potassium levels.

C. Hydrochlorothiazide is a thiazide diuretic that acts on the distal convoluted tubule to increase potassium excretion, similar to Indapamide. However, this option is incorrect since it would also lead to increased potassium excretion, which is not desired for the patient with low potassium levels.

**Clinical Pearl:** When prescribing diuretics, consider the patient's potassium level, as it affects the choice of the diuretic to be used. Low potassium levels can lead to muscle weakness, hypotension, and potentially life-threatening cardiac arrhythmias, making it crucial to choose a potassium-sparing diuretic like Spironolactone (D) rather than a potassium-losing diuretic like Furosemide (A) or Indapamide (B) or Hydrochlorothiazide (C).